Cartherics, UniQuest, and University of Sydney Enter Agreements to Advance Cardiac Cellular Therapy for Heart Disease Using iPSC-Derived Cardiomyocytes, Aiming to Regenerate Damaged Heart Tissue and Improve Patient Outcomes.
Cartherics, UniQuest, and University of Sydney Enter Agreements to Advance Cardiac Cellular Therapy for Heart Disease Using iPSC-Derived Cardiomyocytes, Aiming to Regenerate Damaged Heart Tissue and Improve Patient Outcomes.